Description
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
Product Unit Size | Cost | Quantity | Stock |
---|
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
Cas No. | 1638286-64-2 |
---|---|
Purity | ≥95% |
Formula | C40H49NO12 |
Formula Wt. | 735.83 |
Synonym | De-boc-Cabazitaxel |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
NSAID; TREK1 K+ potentiator, voltage-gated Na+ ...
Non-depolarizing NMJ blocker; nAChR and M2/3 mA...
Endogenous sterol component of animal cell memb...
R-type Ca2+ and voltage-gated Na+ channel block...
Hydroxycinnamic acid found in various plant sou...
Induces cardiomyogenic effects in pluripotent c...
Inhibitor of EGFR.
Endogenous bombesin-like peptide, involved in f...
Opioid peptide; δOR agonist.
Diterpene found in coffee beans.
Staurosporine analog; PKC inhibitor, TrkA/B ant...
Pyrrolopyrimidine; Akt inhibitor.
Mycotoxin produced by species of Aspergillus; D...
Benzimidazole; microtubule polymerization inhib...
p110β PI3K inhibitor.
Antiviral againt SARS-CoV-2
CCK antagonist.
Endogenous peptide fragment, immunostimulant; ...
5-HT2/3/6/7, D2/3/4, histamine H1, α1-adrenerg...
AurKA/B inhibitor.